Telegram -- WORCESTER — ECI Biotech, a privately held company that develops protein-based sensors to detect pathogens, has entered into licensing and manufacturing agreements with Systagenix for production of diagnostic sensors for wound management.
Telegram -- WORCESTER — ECI Biotech, a privately held company that develops protein-based sensors to detect pathogens, has entered into licensing and manufacturing agreements with Systagenix for production of diagnostic sensors for wound management.
